Join Gregory Vladimer as he and Mike Tarselli discuss how his company, Allcyte, uses a combination of screening, image analysis, and deep learning models to deliver tailored therapies to cancer patients.
Upcoming SLAS Events:
SLAS Building Biology in 3D Symposium
SLAS Europe 2024 Conference and Exhibition